Nuclear receptor subfamily 2 group F member 1 (NR2F1) is an established biomarker of tumor dormancy that promotes quiescence of various types of cancer cells, including breast, prostate, and squamous cell carcinoma of the head and neck [18,19]. This evidence concerns the gene NR2F1 and squamous cell carcinoma.